BiotechTube

Imetelstat sodium

Phase 2Active
0 watching 0 views this week⚡ Active
47
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Myelodysplastic Syndromes

Conditions

Myelodysplastic Syndromes, Acute Myeloid Leukemia

Trial Timeline

Jun 5, 2023 → Jun 1, 2026

NCT ID
NCT05583552

About Imetelstat sodium

Imetelstat sodium is a phase 2 stage product being developed by Geron for Myelodysplastic Syndromes. The current trial status is active. This product is registered under clinical trial identifier NCT05583552. Target conditions include Myelodysplastic Syndromes, Acute Myeloid Leukemia.

Hype Score Breakdown

Clinical
17
Activity
12
Company
5
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT05583552Phase 2Active

Competing Products

20 competing products in Myelodysplastic Syndromes

See all competitors
ProductCompanyStageHype Score
NEX-18a injection + Azacitidine InjectionNanexa ABPhase 1
28
JSP191Jasper TherapeuticsPhase 1
25
Humanized anti-CD117 Monoclonal Antibody (JSP191)Jasper TherapeuticsPhase 1
25
GTB-3550 TriKE® Phase I + GTB-3550 TriKE® Phase IIGT BiopharmaPhase 1/2
33
Erlotinib HydrochlorideAstellas PharmaPhase 2
52
Decitabine + Decitabine + DecitabineEisaiPhase 2
52
Decitabine + Valproic AcidEisaiPhase 2
52
decitabine + decitabineEisaiPhase 2
52
decitabine + azacitidineEisaiApproved
85
DecitabineEisaiPhase 2
52
decitabine + decitabine + decitabine + decitabineEisaiPhase 1
33
Decitabine, Arsenic Trioxide and Ascorbic AcidEisaiPhase 2
52
Subcutaneous DecitabineEisaiPhase 1
33
DecitabineEisaiPhase 2
52
Galunisertib + PlaceboEli LillyPhase 2/3
65
DSP-7888Sumitomo PharmaPhase 1/2
41
TP-0184Sumitomo PharmaPhase 1/2
41
DecitabineJohnson & JohnsonPhase 2
52
Epoetin alfaJohnson & JohnsonPhase 2
52
ZARNESTRA, tipifarnib, R115777Johnson & JohnsonPhase 2
52

Other Products from Geron

Imetelstat + Best Available Therapy (BAT)Phase 3
72
Imetelstat Sodium + PlaceboPhase 2/3
60
Imetelstat (7.5 mg/kg) + lenalidomide standard of care + Imetelstat (9.4 mg/kg)Phase 2
47
ImetelstatPhase 2
47
Imetelstat sodium + Bevacizumab + PaclitaxelPhase 2
47